Mecamylamine
See all 3 papers on mecamylamine
At a glance
The findings reach mice, none yet in people. 2 independent labs in 1 country; 2 trials, none about aging, 1 with no results posted.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 2 independent labs in 1 country
- 2 trials, none about aging, 1 with no results posted
What did studies of mecamylamine find?
2Studies of mecamylamine measured 2 outcomes: IL10 and memory retrieval.
IL10
downin rats1
1 study
IL10
downin rats1
Mecamylamine decreases IL10 in ischemia-reperfusion injury model.
“as well as reduced Il10 in the IRI + Mec group.”
Animalsin ischemia-reperfusion injury modelkidney
Research in pharmaceutical sciences
Memory retrieval
downin rats1
1 study
Memory retrieval
downin rats1
Mecamylamine impairs memory retrieval in rats (combined with ineffective dose (2mg/kg) of TAM).
“Pre-test intra-CA1 microinjection of mecamylamine (0.1-0.3μg/rat) plus 2mg/kg (an ineffective dose) of TAM impaired memory retrieval.”
Animalscombined with ineffective dose (2mg/kg) of TAMCA10.1-0.3μg/ratfemales
Neuroscience
Trial sponsors
Company1 trialPhase 2574 people
Latest
Research in Pharmaceutical Sciences
Klotho microinjection into the RVLM attenuates acute kidney injury via interaction with the cholinergic anti-inflammatory pathway in rats
Experiments in ratsAcute kidney injury
Human Psychopharmacology
Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance
Non-randomized trial in 40 peopleEstradiol